AVITA Medical opened lower at $17.16, compared with its previous close of $17.30. In the last trading session, the stock traded between $16.70 and $17.57. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in AVITA Medical is now worth
$ 97.60
Resulting in a loss of
$ 2.40 (2.40%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-1.14 (-6.57%)
Day High
$17.57
Day Low
$16.70
Day Open
$17.16
Prev Close
$17.30
Volume
4,36,533
1W Return
-0.79%
1M Return
20.93%
3M Return
96.61%
6M Return
269.86%
1Y Return
308.16%
Fundamentals
Market Cap ($ Mn)
508
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
-224.02%
EPS (TTM)
$-0.20
Investment Returns
1 Week
-0.79%
1 Month
20.93%
3 Months
96.61%
6 Months
269.86%
9 Months
320.91%
Financials
Quarterly
All values in $ Mn
18.4
Jun 25
17.1
Sep 25
17.6
Dec 25
19.3
Mar 26
21.7
Jun 26
26.1
Sep 26
Updates
12Nov
TD Cowen raises AVITA Medical price target to $22, maintains Buy
TD Cowen raised AVITA Medical's price target from $20 to $22. The firm maintained a Buy rating on the stock. The new target represents a 10% increase over the previous level.
Today
7Nov
Lake Street raises AVITA Medical price target to $20, maintains Buy
Lake Street raises AVITA Medical price target from $12 to $20. Analyst Frank Takkinen maintains a Buy rating on the stock. The price target increase represents an $8 upside revision.
6 days ago
6Nov
BTIG maintains Buy on Avita Medical, raises price target to $21
BTIG maintains a Buy rating on Avita Medical. Price target raised from $15 to $21. Analyst Ryan Zimmerman issued the rating and target update.
6 days ago
6Nov
AVITA Medical Q3FY26 Results: Revenue jumps 53% YoY to $26.1 million
Revenue rose 53% YoY to $26.1 million in Q3FY26. Net cash use reduced to $0.6 million from $3.2 million in Q2. Full-year FY26 revenue guidance raised to $92-$94 million. Gross margin expanded to 84%, up 210 bps sequentially. Going concern doubt alleviated following credit facility drawdown.
7 days ago
21Oct
Avita Medical Q3FY26 Results: Earnings call set for November 5
Avita Medical will report Q3FY26 financial results on November 5, 2026. Conference call scheduled for 1:30 pm Pacific Time on the same day. Company specializes in RECELL technology for thermal burn and trauma wounds.
23 days ago
12Oct
AVITA Medical Q2FY26 Results: Revenue up 18% YoY to $21.7 million, guidance raised
Revenue rose 18% YoY to $21.7 million, crossing $20 million quarterly for the first time. Gross margin improved to 81.9%, while operating expenses fell 6% YoY to $24.6 million. Full-year 2026 revenue guidance raised to $86-89 million, implying 20-24% growth. Net loss narrowed to $7.7 million from $9.9 million in the prior-year quarter. Company targets cash flow breakeven and positive cash generation by Q4 2026.
